Difference between revisions of "Yu D, et al. Lab. Invest. (2014) cited as Ref 351 in DOI: 10.1038/s41392-020-0110-5 (Q9614)"
Jump to navigation
Jump to search
(Created claim: Third Author string (P151): Lee YS, #quickstatements; #temporary_batch_1589999365427) |
(Created claim: DOI Identifier (P138): 10.1038/labinvest.2014.125, #quickstatements; #temporary_batch_1590000649558) |
||
| Property / DOI Identifier | |||
| + | |||
| Property / DOI Identifier: 10.1038/labinvest.2014.125 / rank | |||
| + | Normal rank | ||
Revision as of 18:58, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Yu D, et al. Lab. Invest. (2014) cited as Ref 351 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Yu D
0 references
Shin HS
0 references
Lee YS
0 references
